DEFR14A: Lifeway Foods Exposes Dissident Nominees' Ethical Lapses

Lifeway Foods issues a corrected press release detailing disqualifying track records and ethical failures of dissident director nominees Edward Smolyansky and George Sent.

Summary

• Lifeway Foods issued a corrected press release on December 11, 2025, revising information from December 1, 2025, regarding dissident director nominees Edward Smolyansky and George Sent.
• The release addresses Edward Smolyansky's default on a mortgage, the status of a foreclosure action, and his past use of pseudonyms to post negative information about the Company.
• Lifeway Foods opposes the nomination of Edward Smolyansky and George Sent to its Board of Directors, citing their unfitness to serve and potential risks to shareholder value.
• Edward Smolyansky was terminated for cause as Lifeway's COO in 2022, was intoxicated on multiple occasions during duties, is subject to an emergency protection order against the CEO, and founded a direct competitor.
• Edward Smolyansky is being sued by CIBC Bank USA for defaulting on a $4,551,056.22 Note from 2019, breach of a forbearance agreement, and mortgage foreclosure, with a hearing on CIBC's motion set for February 2026.
• Edward Smolyansky created multiple social media accounts under pseudonyms to post negative statements about Lifeway, even while serving as a Director.
• Ludmila Smolyansky, Edward's mother, faces over $2.3 million in federal and state tax liens.
• George Sent, a Managing Director of Cascadia Capital, is criticized for aligning with Edward Smolyansky despite previously chairing a special committee that investigated Edward's misconduct.
• The Company suggests the Smolyanskys' personal financial distress and limited share sales are fueling demands for a quick sale of Lifeway at any price, potentially conflicting with other shareholders' best interests.
• Neither Edward nor Ludmila Smolyansky have purchased Lifeway common stock in the last five years, but have sold over 2.5 million shares, including 1.1 million below $8.00 per share.
• Edward Smolyansky has not secured employment since his removal from Lifeway and claims to have invested substantially in a new venture, which he describes as a kefir company competing with Lifeway.
• Institutional Shareholder Services (ISS) recommended in July 2025 that Lifeway shareholders DO NOT VOTE on proposals put forth by the Dissident group, including Mr. Sent.
• Lifeway's Board and management have delivered strong results: 788% total shareholder return over the past five years, ~123% revenue growth since FY2019, and six years of uninterrupted quarterly net sales growth.
• Net sales in Q3 2025 were $57.1 million, a 29% volume-led increase, with gross margin expansion of 300 basis points and net income growth of 19%.
• The Board has been refreshed, adding independent directors with relevant expertise (accounting, finance, business growth, dairy consumer products) since 2021.
• In 2023, Ludmila Smolyansky was not renominated, increasing Board independence.
• In October and November 2025, the Board appointed four new independent members (Rachel Drori, Andee Harris, Susie Hultquist, Kirk Chartier) with prior written approval from Danone, pursuant to a Cooperation Agreement signed on September 30, 2025.
• Pol Sikar will not be nominated for re-election at the 2025 Annual Meeting, and Jason Scher will not be nominated at the 2026 Annual Meeting.
• The Board will be controlled by New Independent Board Members at or prior to the 2026 Annual Meeting.

Sentiment

Score: 8

Explanation: The company reports strong financial performance with significant shareholder returns, revenue growth, and consistent net sales growth. It also highlights proactive corporate governance improvements. The negative aspects primarily relate to the character and financial issues of the dissident nominees, which the company is actively combating.

Positives

• 788% total shareholder return over the past five years, significantly outperforming peers and the S&P 500.
• ~123% revenue growth since FY2019.
• Six years of uninterrupted quarterly net sales growth, including a record-breaking Q3 2025.
• Q3 2025 net sales of $57.1 million, a 29% volume-led increase.
• Q3 2025 gross margin expansion of 300 basis points and net income growth of 19%.
• Ongoing Board refreshment process, adding independent directors with relevant expertise (accounting, finance, business growth, dairy consumer products).
• Cooperation Agreement with Danone North America PBC leading to the appointment of four new independent board members.
• Board will be controlled by New Independent Board Members at or prior to the 2026 Annual Meeting, enhancing governance.

Negatives

• Edward Smolyansky's termination for cause as COO in 2022 due to misconduct (intoxication during duties).
• Emergency protection order against Edward Smolyansky prohibiting communication with or proximity to Lifeway's CEO, Julie Smolyansky.
• Edward Smolyansky founded a direct competitor to Lifeway.
• Edward Smolyansky defaulted on a $4,551,056.22 mortgage Note and is facing a foreclosure lawsuit from CIBC Bank USA.
• Edward Smolyansky used pseudonyms on social media to post negative information about Lifeway, even while a director.
• Ludmila Smolyansky faces over $2.3 million in federal and state tax liens.
• Concerns about George Sent's judgment for aligning with Edward Smolyansky despite prior involvement in investigating Edward's misconduct.
• Dissident nominees' personal financial distress may drive demands for a quick sale of the Company at any price, potentially not in the best interest of all shareholders.
• Dissidents have sold over 2.5 million shares in the last five years, including 1.1 million below $8.00 per share, and have not purchased any.

Risks

• The Dissident Nominees pose a clear risk to shareholder value due to their disqualifying issues and ethical concerns.
• Edward Smolyansky's personal financial distress and that of Ludmila Smolyansky could lead them to vote in ways that benefit them personally but not other shareholders, particularly by pushing for a quick sale of the Company at any price.
• Edward Smolyansky's history of contradictory statements, misinformation, and financial irresponsibility raises concerns about his fitness to serve as a fiduciary.
• Potential for continued proxy contest and disruption from dissident shareholders.
• General risks mentioned in forward-looking statements: price competition, decisions of customers/consumers, actions of competitors, changes in commodity pricing, government regulation effects, possible delays in new product introduction, and customer acceptance of products/services.

Future Outlook

Lifeway is well positioned for continued success, either as an independent company or through a transaction that achieves compelling value for shareholders, under the current Board as adjusted in 2026. The Company disclaims any obligation to update forward-looking statements except as required by law.

Management Comments

• "The track record of the Dissident Nominees demonstrates they are unfit to serve on the Company’s Board of Directors and lead the Company and pose a clear risk to shareholder value."
• "The Dissident Nominees have disqualifying issues raising ethical concerns."
• "The Dissidents personal financial distress and that of Ludmila Smolyansky, his mother, and the limited amount of shares they can sell in the aggregate each calendar year seem to be fueling their demands for a sale of the Company at any price and could cause the Dissident Nominees to vote in ways that help the Dissident and his mother personally but are not in the best interests of other shareholders."
• "This pattern of contradictory statements, misinformation, and demonstrated financial irresponsibility raises grave concerns about his fitness to serve as a fiduciary, his ability to act in the best interests of all shareholders rather than himself and his mother, and his judgment in overseeing any public company."
• "Replacing any of the Company’s current directors with the dissident candidates is not in the best interests of Lifeway or its shareholders."
• "We urge you to reject the Dissident’s solicitation on behalf of the Dissident Nominees and the Dissident’s proposal and protect the value of your investment."

Industry Context

Lifeway Foods is a leading U.S. supplier of kefir and fermented probiotic products. The company's strong financial performance, including significant shareholder return and revenue growth, indicates a robust position within the "good for you food" consumer product business. The ongoing proxy contest and the involvement of a managing director from Cascadia Capital highlight the competitive and sometimes contentious nature of corporate governance in the industry, especially when significant shareholder value is at stake. The cooperation agreement with Danone North America PBC, a major player in dairy, suggests strategic alignment or potential future consolidation within the health and wellness food sector.

Comparison to Industry Standards

• Lifeway's 788% total shareholder return over the past five years dramatically outperformed peers in the Russell 3000 Food Producers Index and the S&P 500.
• The Company's ~123% revenue growth since FY2019 demonstrates strong performance relative to industry averages.
• Six years of uninterrupted quarterly net sales growth is a strong indicator of consistent market demand and operational effectiveness, likely exceeding many competitors.
• Q3 2025 gross margin expansion of 300 basis points and net income growth of 19% suggest superior operational execution compared to industry benchmarks.

Management Changes

Corporate Governance

Legal Proceedings

• Edward Smolyansky is being sued in the Circuit Court of Cook County Illinois by CIBC Bank USA for default on a $4,551,056.22 Note executed in 2019, breach of a forbearance agreement, and foreclosure of a mortgage.
• CIBC is moving for Summary Judgment, Motion for Entry of Default, and Motion for Judgment of Foreclosure, with a hearing set for February 2026.
• Edward Smolyansky is subject to an emergency protection order prohibiting him from communicating with or going near Lifeway's CEO, Julie Smolyansky.

Related Party Transactions

• Edward Smolyansky (dissident nominee, former COO, and director) founded a direct competitor of Lifeway.
• Ludmila Smolyansky (Edward's mother, former director, and aligned with Edward in Schedule 13Ds and voting) faces significant tax liens.
• Edward and Ludmila Smolyansky have sold over 2.5 million shares of Lifeway common stock in the last five years, including 1.1 million below $8.00 per share, and have not purchased any.

Stakeholder Impact

• Shareholders: The company argues that rejecting dissident nominees protects shareholder value by preventing individuals with ethical concerns and potential conflicts of interest from joining the Board. Strong financial performance and improved governance aim to benefit all shareholders. The dissident's push for a quick sale at any price could negatively impact long-term shareholders.
• Management/Employees: The emergency protection order against Edward Smolyansky involving the CEO highlights potential workplace disruption and conflict. The company's strong performance and stable governance could provide a more secure environment.
• Customers/Consumers: Continued strong performance and focus on "good for you food" products, as evidenced by sales growth, suggest positive impact on product availability and quality.
• Creditors: Edward Smolyansky's default on a significant mortgage note and associated foreclosure lawsuit indicates personal financial distress that could raise concerns if he were to hold a fiduciary role.

Next Steps

• Shareholders are urged to reject the Dissident's solicitation and proposals at the 2025 annual meeting.
• Hearing on CIBC's Motion for Summary Judgment, Entry of Default, and Judgment of Foreclosure in February 2026.
• Jason Scher will not be nominated for re-election at the 2026 Annual Meeting.
• The Board will be controlled by New Independent Board Members at or prior to the 2026 Annual Meeting.

Key Dates

Recommendation

The company demonstrates exceptional financial performance with 788% total shareholder return over five years, 123% revenue growth since FY2019, and six consecutive years of quarterly net sales growth. Q3 2025 results show strong momentum with 29% net sales increase, 300 basis points gross margin expansion, and 19% net income growth. The Board is actively enhancing corporate governance by adding highly qualified independent directors and reducing the influence of long-serving members, including a cooperation agreement with Danone. The company is effectively countering a dissident proxy challenge by highlighting the nominees' significant ethical and financial disqualifications, which, if successful, would remove a potential source of instability. These factors collectively indicate a well-managed company with strong growth prospects and improving governance, making it an attractive investment.

Keywords

Lifeway Foods, LWAY, Proxy Contest, Shareholder Activism, Corporate Governance, Board of Directors, Kefir, Probiotic Products, Financial Performance, SEC Filing, Dissident Nominees, Edward Smolyansky, George Sent, Danone, Shareholder Return, Revenue Growth, Net Sales, Gross Margin, Net Income